Effectiveness of AOP's on abatement of emerging pollutants and their oxidation intermediates: Nicotine removal with Fenton's Reagent

Desalination

Volumn 280, Issue 1-3, 2011, Pages 108-113

  Rodriguez, Sergio ^a   Santos, Aurora ^a   Romero, Arturo ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

AOPs; Emerging pollutants; Fenton's Reagent; Nicotine; Toxicity

Indexed keywords

AOPS; EMERGING POLLUTANTS; FENTON'S REAGENTS; INITIAL OXIDATION; MICROTOX; NICOTINE; OXIDATION PROCESS; TARGET POLLUTANTS; TOXIC INTERMEDIATES;

HYDROGEN; HYDROGEN PEROXIDE; OXIDATION; POLLUTION; PYRIDINE; TOXICITY;

REACTION INTERMEDIATES;

HYDROGEN PEROXIDE; OXIDATION; POLLUTANT; TEMPERATURE EFFECT; TOTAL ORGANIC CARBON; TOXICITY;

EID: 80053325095     PISSN: 00119164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.desal.2011.06.055     Document Type: Article

References (60)

1. Rosal R., Rodríguez A., Perdigón-Melón J.A., Petre A., García-Calvo E., José Gómez M., Agüera A., Fernández-Alba A.R. Degradation of caffeine and identification of the transformation products generated by ozonation. Chemosphere 2009, 74(6):825-831.
2. 2. Catal. Today 2009, 144(1-2):124-130.
3. Dalmázio I., Santos L.S., Lopes R.P., Eberlin M.N., Augusti R. Advanced oxidation of caffeine in water: on-line and real-time monitoring by electrospray ionization mass spectrometry. Environ. Sci. Technol. 2005, 39(16):5982-5988.
4. Barcelo D. Emerging pollutants in water analysis. Trends Anal. Chem. 2003, 22(10):XIV-XVI.
5. Muñoz I., Gómez M.J., Molina-Díaz A., Huijbregts M.A.J., Fernández-Alba A.R., García-Calvo E. Ranking potential impacts of priority and emerging pollutants in urban wastewater through life cycle impact assessment. Chemosphere 2008, 74:37-44.
6. Arcand-Hoy L.D., Nimrod A.C., Benson W.H. Endocrine-modulating substances in the environment estrogenic effects of pharmaceutical products. Int. J. Toxicol. 1998, 17(2):139-158.
7. Halling-Sørensen B., Nielsen S.N., Lanzky P.F., Ingerslev F., Lützhøft H.C.H., Jørgensen S.E. Occurrence, fate and effects of pharmaceutical substances in the environment - a review. Chemosphere 1998, 36(2):357-394.
8. Kümmerer K. Resistance in the environment. J. Antimicrob. Chemother. 2004, 54(2):311-320.
9. Westerhoff P., Yoon Y., Snyder S., Wert E. Fate of endocrine-disrupter, pharmaceuticals and personal care product chemicals during simulated drinking water treatment process. Environ. Sci. Technol. 2005, 39:6649-6663.
10. Adams C., Wang Y., Loftin K., Meyer M. Removal of antibiotics from surface and distilled water in conventional water treatment process. J. Environ. Eng. 2002, 128:253-260.
11. Petrovic M., Diaz A., Ventura F., Barcelo D. Occurrence and removal of estrogenic short chain ethoxy nonylphenolic compound and their halogenated derivatives during drinking water production. Environ. Sci. Technol. 2003, 27:4442-4448.
12. Vieno N.M., Tuhkanen T., Kronberg L. Removal of pharmaceuticals in drinking water treatment: effect of chemical coagulation. Environ. Technol. 2006, 27:183-192.
13. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 1998, 32(11):3245-3260.
14. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., Buxton H.T. Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 2002, 36(6):1202-1211.
15. Petrovic M., Gonzalez S., Barcelo D. Analysis and removal of emerging contaminants in wastewater and drinking water. Trends Anal. Chem. 2003, 22(10):685-696.
16. Klavarioti M., Mantzavinos D., Kassinos D. Removal of residual pharmaceuticals from aqueous systems by advanced oxidation processes. Environ. Int. 2009, 35:402-417.
17. Filale-Meknassi Y., Tyagi R.D., Surampalli R.Y., Barata C., Riva M.C. Endocrine-disrupting compounds in wastewater, sludge-treatment processes, and receiving waters: overview, practice periodical of hazardous. Toxic Radioact. Waste Manage. ASCE 2004, 8(1):39-56.
18. Abu-Zeid N., Nakhla G., Farooq S., Osei-Twum E. Activated carbon adsorption in oxidising environment. Water Res. 1995, 29:653-660.
19. Schafer A.I., Nghiem L.D., Waite T.D. Removal of the natural hormone estrone from solution using nanofiltration and reverse osmosis. Environ. Sci. Technol. 2003, 37:182-188.
20. Yoon Y., Westerhoff P., Snyder S.A., Wert E.C. Nanofiltration and ultrafiltration of endocrine disrupting compounds, pharmaceuticals and personal care products. J. Membr. Sci. 2006, 270:88-100.
21. Nghiem L.D., Schafer A.I., Elimelech M. Removal of natural hormones by nanofiltration membranes: measurement, modeling and mechanisms. Environ. Sci. Technol. 2004, 38:1888-1896.
22. Yoon Y., Westerhoff P., Yoon J., Snyder S.A. Removal of 17β estradiol and fluoranthene by nanofiltration and ultrafiltration. J. Environ. Eng. ASCE 2004, 130(12):1460-1467.
23. Gerard-Gomeza C., Dufauxb M., Morela J., Naccacheb C., Ben Taarit Y. Catalytic oxidation of nicotine over zeolite-supported platinum. Appl. Catal. A 1997, 165(1-2):371-377.
24. Huber M.M., Gobel A., Joss A., Hermann N., Loffler D., Mcardell A.R., Siegrist H., Ternes T.A., Gunten U. Oxidation of pharmaceuticals during ozonation of municipal wastewater effluents: a pilot study. Environ. Sci. Technol. 2005, 39:4290-4299.
25. Ikehata K., Gamal El-Din M., Snyder S.A. Ozonation and advanced oxidation treatment of emerging organic pollutants in water and wastewater. Ozone Sci. Eng. 2008, 30(1):21-26.
26. Ikehata K., Naghashkar N.J., Gamal Ei-Din M. Degradation of aqueous pharmaceuticals by ozonation and advanced oxidation processes: a review. Ozone Sci. Eng. 2006, 28(6):353-414.
27. 2/UV system. Water Res. 2003, 37:993-1004.
28. Andreozzi R., Canterino M., Marotta R., Paxeus N. Antibiotic removal from wastewaters: the ozonation of amoxicillin. J. Hazard. Mater. 2005, 122:243-250.
29. 2+ and UVA light. Appl. Catal. B Environ. 2006, 66:228-240.
30. Lei H., Snyder S.A. 3D QSPR models for the removal of trace organic contaminants by ozone and free chlorine. Water Res. 2007, 41:4051-4060.
31. Nakada N., Shinohara H., Murata A., Kiri K., Managaki S., Sato N., Takada H. Removal of selected pharmaceuticals and personal care products (PPCPs) and endocrine-disrupting chemicals (EDCs) during sand filtration and ozonation at a municipal sewage treatment plant. Water Res. 2007, 41:4373-4382.
32. Hua W., Bennett E.R., Letcher R.J. Ozone treatment and the depletion of detectable pharmaceuticals and atrazine herbicide in drinking water sourced from the upper Detroit River, Ontario, Canada. Water Res. 2006, 40:2259-2266.
33. Rosal R., Rodriguez A., Perdigon-Melon J.A., Petre A., Garcia-Calvo E., Gomez M.J., Aguera A., Fernandez-Alba A.R. Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation. Water Res. 2010, 44:578-588.
34. Shemer H., Kunukcu Y.K., Linden K.G. Degradation of the pharmaceutical metronidazole via UV, Fenton and photo-Fenton processes. Chemosphere 2006, 63:269-276.
35. Pereira V.J., Linden K.G., Weinberg H.S. Evaluation of UV irradiation for photolytic and oxidative degradation of pharmaceutical compounds in water. Water Res. 2007, 41:4413-4423.
36. Rosenfeldt E.J., Chen P.J., Kullman S., Linden K.G. Destruction of estrogenic activity inwater using UV advanced oxidation. Sci. Total Environ. 2007, 377:105-113.
37. 2-enhanced photodegradation of nicotine and phosphamidon. Ind. Eng. Chem. Res. 2009, 48:3955-3963.
38. Munoz I., Peral J., Ayllon J.A., Malato S., Passarinho P., Domenech X. Life cycle assessment of a coupled solar photocatalytic-biological process for wastewater treatment. Water Res. 2006, 40:3533-3540.
39. Klamerth N., Malato S., Maldonado M.I., Aguera A., Fernandez-Alba A.R. Application of photo-Fenton as a tertiary treatment of emerging contaminants in municipal wastewater. Environ. Sci. Technol. 2010, 44:1792-1798.
40. 2 photocatalysis. Water Res. 2008, 42:3480-3488.
41. Sires I., Arias C., Cabot P.L., Centellas F., Garrido J.A., Rodriguez R.M., Brillas E. Degradation of clofibric acid in acidic aqueous medium by electro-Fenton and photoelectro-Fenton. Chemosphere 2007, 66:1660-1669.
42. 2 in a pilot plant. Catal. Today 2010, 151:107-113.
43. Torriero A.A.J., Tonn C.E., Sereno L., Raba J. Electrooxidation mechanism of non-steroidal anti-inflammatory drug piroxicam at glassy carbon electrode. J. Electroanal. Chem. 2006, 588:218-225.
44. Murugananthan M., Yoshihara S., Rakuma T., Uehara N., Shirakashi T. Electrochemical degradation of 17β-estradiol (E2) at boron-doped diamond (Si/BDD) thin film electrode. Electrochim. Acta 2007, 52:3242-3249.
45. Tekin H., Bilkay O., Ataberk S.S., Balta T.H., Ceribasi I.H., Sanin F.D., Dilek F.B., Yetis U. Use of Fenton oxidation to improve the biodegradability of a pharmaceutical wastewater. J. Hazard. Mater. 2006, 136:258-265.
46. Xing M., Deng C., Godefroid B., Yang J. Treatment of pharmaceutical wastewater containing recalcitrant compounds in a Fenton-coagulation process. J. Environ. Sci. 2006, 18:459-463.
47. Fernandez-Alba A.R., Hernando D., Aguera A., Caceres J., Malato S. Toxicity assays: a way for evaluating AOPs efficiency. Water Res. 2002, 36(17):4255-4262.
48. Andreozzi R., Campanella L., Fraysse B., Garric J., Gonnella A., Lo Giudice R., Marotta R., Pinto G., Pollio A. Effects of advanced oxidation processes (AOPs) on the toxicity of a mixture of pharmaceuticals. Water Sci. Technol. 2004, 50(5):23-28.
49. Dantas R.F., Canterino M., Marotta R., Sansa C., Esplugas S., Andreozzi R. Bezafibrate removal by means of ozonation: primary intermediates, kinetics, and toxicity assessment. Water Res. 2007, 41(12):2525-2532.
50. Perez-Estrada L.A., Malato S., Aguera A., Fernandez-Alba A.R. Degradation of dipyrone and its main intermediates by solar AOPs identification of intermediate products and toxicity assessment. Catal. Today 2007, 129(1-2):207-214.
51. Andreozzi R., Di Somma I., Pollio A., Pinto G., Sanchirico R. Toxicity of unwanted intermediates and products formed during accidental thermal decomposition of chemicals. J. Hazard. Mater. 2008, 150(2):433-437.
52. la Farre M., Perez S., Kantiani L., Barcelo D. Fate and toxicity of emerging pollutants, their metabolites and transformation products in the aquatic environment. Trac, Trends Anal. Chem. 2008, 27(11):991-1007.
53. Baran W., Adamek E., Sobczak A., Makowski A. Photocatalytic degradation of sulfa drugs with TiO2, Fe salts and TiO2/FeCl3 in aquatic environment-kinetics and degradation pathway. Appl. Catal. B Environ. 2009, 90(3-4):516-525.
54. Di Somma I., Pollio A., Pinto G., de Falco M., Pizzo E., Andreozzi R. A procedure for the assessment of the toxicity of intermediates and products formed during the accidental thermal decomposition of a chemical species. J. Hazard. Mater. 2010, 176(1-3):575-578.
55. Okamoto M., Kita T., Okuda H., Tanaka T., Nakashima T. Effects of aging on acute toxicity of nicotine in rats. Pharmacol. Toxicol. 1994, 75(1):1-6.
56. Zander Å., Findlay P., Renner T., Sellergren B. Analysis of nicotine and its oxidation products in nicotine chewing gum by a molecularly imprinted solid phase extraction. Anal. Chem. 1998, 70(15):3304-3314.
57. Huerta-Fontela M., Galceran M.T., Ventura F. Stimulatory drugs of abuse in surface waters and their removal in a conventional drinking water treatment plant. Environ. Sci. Technol. 2008, 42(18):6809-6816.
58. Santos A., Yustos P., Rodriguez S., Garcia-Ochoa F. Wet oxidation of phenol, cresols and nitrophenols catalyzed by activated carbon in acid and basic media. Appl. Catal. B 2006, 65:269-281.
59. Abele E., Abele R., Lukevics E. Pyridine oximes: synthesis, reactions and biological activity. Chem. Heterocycl. Compd. 2003, 39(7):825-865.
60. Liu S.M., Wu C.H., Huang H.J. Toxicity and anaerobic biodegradability of pyridine and its derivatives under sulfidogenic conditions. Chemosphere 1998, 36(10):2345-2357.